ELR-105813

N/A

Report date: 2025/05/20 15:00:37
NME

Base Information

Drug NameELR-105813
Drug Alias NameELR-105813
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor 1 alpha inhibitors
TargetsHypoxia-inducible factor 1 alpha
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElara Pharmaceuticals GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElara Pharmaceuticals GmbH
Active IndicationsN/A
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A